Rapid quantification of lisinopril in human plasma by liquid chromatography/tandem mass spectrometry

Biomedical Chromatography

Volumn 21, Issue 4, 2007, Pages 415-421

  Qin, Weiwei ^a   Zhang, Zunjian ^a   Tian, Yuan ^a   Xu, Fengguo ^a   Wang, Na ^a   Chen, Yun ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

LC MS MS; Lisinopril; Pharmacokinetics

Indexed keywords

ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA (HUMAN); POSITIVE IONS; PROTEINS;

HUMAN PLASMAS; INTERNAL STANDARDS; LC-MS-MS; LC.MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; LISINOPRIL; PERCHLORIC ACIDS; PLASMA SAMPLES; PROTEIN PRECIPITATION;

PHARMACOKINETICS;

ACETIC ACID; AMMONIUM ACETATE; ENALAPRILAT; LISINOPRIL; METHANOL; PERCHLORIC ACID;

ACCURACY; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CALIBRATION; CHINESE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; ELECTROSPRAY; ELUTION; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PH; PRECIPITATION; QUANTITATIVE ASSAY; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; VOLUNTEER;

EID: 34147144199     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.774     Document Type: Article

References (13)

1. Chen Z, Zhang J, Yu J, Cao G, Wu X and Shi Y. Selective method for the determination of cefdinir in human plasma using liquid chromatography electrospray ionization tandam mass spectrometry. Journal of Chromatography B 2006; 834: 163.
2. Huang J, Xu Y, Liu F, Gao S and Guo Q. Development of a rapid liquid chromatography tandem mass spectrometry assay for the quantification of lisinopril in human plasma. Rapid Communication in Mass Spectrometry 2006; 20: 248.
3. Kousoulos C, Tsatsou G, Dotsikas Y and Loukas YL. Development of a rapid liquid chromatography tandem mass spectrometry method for the determination of lisinopril, applicable for a bioequivalence study, employing a 96-well format solid phase extraction protocol. Analytica Chimica Acta 2005; 551: 177.
4. Langtry HD and Markham A. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients. Drugs and Aging 1997; 10: 131.
5. Leis HJ, Fauler G, Raspotnig G and Windischhofer W. Quantitative determination of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry. Rapid Communications in Mass Spectrometry 1998; 12: 1591.
6. Leis HJ, Fauler G, Raspotnig G and Windischhofer W. An improved method for the measurement of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/ negative ion chemical ionization mass spectrometry. Rapid Communications in Mass Spectrometry 1999; 13: 650.
7. Medvedovici A, Albu F, Georgita C and David V. Non-extractive procedure followed by LC/APCI MS/MS analysis of trimetazidine in plasma samples for assessing bioequivalence of immediate/modified release formulations. Biomedical Chromatography 2005; 19: 549.
8. Noble TA and Murray KM. Lisinopril: a nonsulfhydryl angiotensin-converting enzyme inhibitor. Clinical Pharmacy 1988; 7: 659.
9. Padua AAF, Barrientos-Astigarraga RE, Rezende VM, Mendes GD and De Nucci G. Lisinopril quantification in human plasma by liquid chromatography-electrospray tandem mass spectrometry. Journal of Chromatography B 2004; 809: 211.
10. Ramakrishna NVS, Vishwottam KN, Kotesbwara M, Manoj S, Santosh M, Chidambara J, Sumatha B and Varma DP. Rapid quantification of gabapentin in human plasma by liquid chromatography/tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2006; 40: 360.
11. Sagirli O and Ersoy L. An HPLC method for the determination of lisinopril in human plasma and urine with fluorescence detection. Journal of Chromatography B 2004; 809: 159.
12. Tsakalof A, Bairachtari K and Georgarakis M. Lisinopril quantification in human plasma by liquid chromatograpby-electrospray tandem mass spectrometry. Journal of Chromatograhpy B 2003; 783: 425.
13. Wong Y and Charles BG. Determination of the angiotensin-converting enzyme inhibitor lisinopril in urine using solid-phase extraction and reversed-phase higb-performance liquid chromatography. Journal of Chromatography B 1995; 673: 306.